Literature DB >> 87398

Studies with anti-growth hormone receptor antibodies.

M J Waters, H G Friesen.   

Abstract

Antisera against a partially purified growth hormone receptor derived from rabbit liver were generated in guinea pigs. The antisera specifically inhibited the binding of 125I-ovine growth hormone (oGH) to liver membranes but had no effect on the binding of 125I-ovine prolactin to rabbit mammary gland receptors. These antisera did not bind or destroy 125I-oGH. Moreover, the binding of labeled growth hormone to membrane particles derived from liver of several species was also inhibited by the antisera, thus suggesting that immunological determinants of the growth hormone receptor of several species are similar. gamma-Globulin fractions derived from the antisera were responsible for the inhibition. In addition 125I-gamma-globulin derived from one antiserum bound to membrane pellets with a corresponding decline in 125I-oGH binding. Kinetic analysis of inhibition of 125I-oGH binding suggested a hyperbolic competitive inhibition, a point of view which is favored by the demonstration of a hormone receptor . antibody complex. The availability of the antireceptor sera confirmed previous data that differential affinity chromatography separated growth hormone and prolactin receptors in solubilized rabbit liver membrane preparations. The antireceptor sera will be useful probes in further characterization of the growth hormone receptor.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 87398

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Monoclonal antibodies to the pituitary growth-hormone receptor by the anti-idiotypic approach. Production and initial characterization.

Authors:  M I Elbashir; T Brodin; B Akerström; J Donnér
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

2.  Immunocytochemical demonstration of the binding and internalization of growth hormone in GERL of Chang hepatoma cells.

Authors:  J J Wang; J P Chang; C S Teng
Journal:  Cell Tissue Res       Date:  1990-11       Impact factor: 5.249

3.  Evolution of studies on antireceptor antibodies and disease.

Authors:  P R Carnegie; I R Mackay
Journal:  Springer Semin Immunopathol       Date:  1982

4.  Inhibition of renal adenylate cyclase by plasma from uremic patients.

Authors:  H Jüppner; R D Hesch
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

5.  Membrane modification differentially affects the binding of the lactogenic hormones human growth hormone and ovine prolactin.

Authors:  A Bhattacharya; B K Vonderhaar
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.